Bausch Health Companies Inc. (NASDAQ:BHC) | Finanzwire

Basculer en Français

8302	Companies
115121	Keywords
55446	Articles
62530	Press releases

Headlines Articles Press releases Bausch Health Companies Inc.

Home
Companies
Bausch Health Companies Inc.

BRIEF

published on 04/11/2024 at 22:20, 7 months 10 days ago

Bausch Health to Unveil First-Quarter 2024 Financial Results

Financial Results Conference Call Investor Relations Bausch Health First Quarter 2024
BRIEF

published on 04/11/2024 at 22:20, 7 months 10 days ago

Bausch Health to Announce First-Quarter 2024 Results on May 2

Conference Call Pharmaceutical Industry Investor Relations Bausch Health Quarterly Results
PRESS RELEASE

published on 04/11/2024 at 22:15, 7 months 10 days ago

Bausch Health to Announce First-Quarter 2024 Results on May 2
Bausch Health Companies Inc. to release first-quarter 2024 financial results on May 2, 2024, and host a conference call and webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update

Conference Call Bausch Health Companies Inc. Investor Relations Webcast First-quarter Financial Results
BRIEF

published on 04/11/2024 at 19:08, 7 months 10 days ago

Federal Court Upholds Ruling Against Norwich’s ANDA for XIFAXAN Until 2029

Salix Pharmaceuticals XIFAXAN FDA Approval Bausch Health ANDA
PRESS RELEASE

published on 04/11/2024 at 19:03, 7 months 10 days ago

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Bausch Health Companies Inc. and Salix Pharmaceuticals win U.S. Court of Appeals case over XIFAXAN, affirming FDA approval delay until Oct. 2029. Statements from CEOs included

Bausch Health Companies Inc. Salix Pharmaceuticals XIFAXAN FDA Approval U.S. Court Of Appeals
BRIEF

published on 04/11/2024 at 14:05, 7 months 10 days ago

Acne Vulgaris Treatment PrARAZLO(TM) Now Accessible via BC PharmaCare

Bausch Health Acne Vulgaris PrARAZLO BC PharmaCare Public Drug Plan
PRESS RELEASE

published on 04/11/2024 at 14:00, 7 months 10 days ago

Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
Bausch Health, Canada Inc. announces availability of ARAZLO lotion for acne treatment through BC PharmaCare. ARAZLO offers unique formulation technology to enhance patient tolerability

Bausch Health Acne Treatment BC PharmaCare ARAZLO Lotion Dermatology Portfolio
BRIEF

published on 04/06/2024 at 00:20, 7 months 15 days ago

Bausch Health Files Patent Lawsuit Against Amneal Pharmaceuticals Over Generic Version of XIFAXAN®

XIFAXAN Bausch Health Amneal Pharmaceuticals Patent Lawsuit Gastroenterology
PRESS RELEASE

published on 04/06/2024 at 00:15, 7 months 15 days ago

Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
Bausch Health Companies Inc. files lawsuit against Amneal Pharmaceuticals over XIFAXAN. Lawsuit follows FDA approval request for generic version of XIFAXAN. Bausch Health defends its XIFAXAN intellectual property

Bausch Health Companies Inc. XIFAXAN FDA Approval Lawsuit Intellectual Property
BRIEF

published on 04/03/2024 at 14:05, 7 months 18 days ago

Bausch Health Canada Announces UCERIS Listing In Five Provinces For Distal Ulcerative Colitis Treatment

Pharmaceuticals Ulcerative Colitis Bausch Health UCERIS Canada Healthcare

Accesswire

Published on 11/21/2024 at 22:05, 2 hours ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 15 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 50 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 55 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 4 hours 5 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 5 hours 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 28 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 6 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 13 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 13 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 17 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE